Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:1244-1250
Published online before print April 17, 2008, doi: 10.1161/ATVBAHA.108.166405
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
28/7/1244    most recent
ATVBAHA.108.166405v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lukowski, R.
Right arrow Articles by Feil, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lukowski, R.
Right arrow Articles by Feil, R.
Related Collections
Right arrowRelated Article
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:1244.)
© 2008 American Heart Association, Inc.


Integrative Physiology/Experimental Medicine

Role of Smooth Muscle cGMP/cGKI Signaling in Murine Vascular Restenosis

Robert Lukowski; Pascal Weinmeister; Dominik Bernhard; Susanne Feil; Michael Gotthardt; Joachim Herz; Steffen Massberg; Alma Zernecke; Christian Weber; Franz Hofmann; Robert Feil

From the Institut für Pharmakologie und Toxikologie (R.L., P.W., D.B., F.H.), TU München, Germany; Interfakultäres Institut für Biochemie (S.F., R.F.), Universität Tübingen, Germany; Max-Delbrück-Centrum für Molekulare Medizin (M.G.), Berlin-Buch, Germany; Department of Molecular Genetics (J.H.), UT Southwestern, Dallas, Tex; Deutsches Herzzentrum (S.M.), TU München, Germany; and Institut für Kardiovaskuläre Molekularbiologie (A.Z., C.W.), RWTH Aachen, Germany.

Correspondence to Dr Robert Lukowski, Institut für Pharmakologie und Toxikologie der TUM, Biedersteiner Str. 29, D-80802 München, Germany. E-mail lukowski{at}ipt.med.tu-muenchen.de

Background— Nitric oxide (NO) is of crucial importance for smooth muscle cell (SMC) function and exerts numerous, and sometimes opposing, effects on vascular restenosis. Although cGMP-dependent protein kinase type I (cGKI) is a principal effector of NO, the molecular pathway of vascular NO signaling in restenosis is unclear. The purpose of this study was to examine the functional role of the smooth muscle cGMP/cGKI signaling cascade in restenosis of vessels.

Methods and Results— Tissue-specific mouse mutants were generated in which the cGKI protein was ablated in SMCs. We investigated whether the absence of cGKI in SMCs would affect vascular remodeling after carotid ligation or removal of the endothelium. No differences were detected between the tissue-specific cGKI mutants and control mice at different time points after vascular injury on a normolipidemic or apoE-deficient background. In line with these results, chronic drug treatment of injured control mice with the phosphodiesterase-5 inhibitor sildenafil elevated cGMP levels but had no influence on the ligation-induced remodeling.

Conclusions— The genetic and pharmacological manipulation of the cGMP/cGKI signaling indicates that this pathway is not involved in the protective effects of NO, suggesting that NO affects vascular remodeling during restenosis via alternative mechanisms.


Key Words: nitric oxide • PKG • atherosclerosis • carotid ligation • wire-injury


Related Article:

Are the Mechanisms for NO-Dependent Vascular Remodeling Different From Vasorelaxation In Vivo?
Michael Schleicher and William C. Sessa
Arterioscler Thromb Vasc Biol 2008 28: 1207-1208. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
N. Sawada, H. Itoh, K. Miyashita, H. Tsujimoto, M. Sone, K. Yamahara, Z. P. Arany, F. Hofmann, and K. Nakao
Cyclic GMP Kinase and RhoA Ser188 Phosphorylation Integrate Pro- and Antifibrotic Signals in Blood Vessels
Mol. Cell. Biol., November 15, 2009; 29(22): 6018 - 6032.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
A. N. Keswani, K. J. Peyton, W. Durante, A. I. Schafer, and D. A. Tulis
The Cyclic GMP Modulators YC-1 and Zaprinast Reduce Vessel Remodeling Through Antiproliferative and Proapoptotic Effects
Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2009; 14(2): 116 - 124.
[Abstract] [PDF]


Home page
Mol. Biol. CellHome page
P. Weinmeister, R. Lukowski, S. Linder, C. Traidl-Hoffmann, L. Hengst, F. Hofmann, and R. Feil
Cyclic Guanosine Monophosphate-dependent Protein Kinase I Promotes Adhesion of Primary Vascular Smooth Muscle Cells
Mol. Biol. Cell, October 1, 2008; 19(10): 4434 - 4441.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Schleicher and W. C. Sessa
Are the Mechanisms for NO-Dependent Vascular Remodeling Different From Vasorelaxation In Vivo?
Arterioscler Thromb Vasc Biol, July 1, 2008; 28(7): 1207 - 1208.
[Full Text] [PDF]